Latest news with #KebNi
Yahoo
04-08-2025
- Business
- Yahoo
Exploring High Growth Tech Stocks in Europe August 2025
Amidst a backdrop of global trade tensions and economic uncertainty, the European stock market has seen notable fluctuations, with the pan-European STOXX Europe 600 Index recently declining by 2.57% due to dissatisfaction with a new trade deal framework between the U.S. and EU. Despite these challenges, high-growth tech stocks in Europe continue to capture investor interest as they navigate this complex environment by leveraging innovation and adaptability—key attributes that can help companies thrive even when broader market conditions are less favorable. Top 10 High Growth Tech Companies In Europe Name Revenue Growth Earnings Growth Growth Rating Intellego Technologies 28.42% 47.04% ★★★★★★ KebNi 20.56% 65.02% ★★★★★★ Bonesupport Holding 23.98% 62.26% ★★★★★★ Comet Holding 12.20% 35.81% ★★★★★☆ Lipigon Pharmaceuticals 104.89% 93.94% ★★★★★☆ Yubico 16.27% 23.90% ★★★★★☆ ContextVision 5.83% 39.78% ★★★★★☆ Aelis Farma 79.30% 106.93% ★★★★★☆ SyntheticMR 18.81% 47.40% ★★★★★☆ CD Projekt 33.59% 40.62% ★★★★★☆ Click here to see the full list of 53 stocks from our European High Growth Tech and AI Stocks screener. We're going to check out a few of the best picks from our screener tool. Paradox Interactive Simply Wall St Growth Rating: ★★★★★☆ Overview: Paradox Interactive AB (publ) is a company that develops and publishes strategy and management games for PC and consoles across various regions including the United States, Europe, Sweden, and other international markets, with a market cap of SEK17.26 billion. Operations: The company generates revenue primarily from its computer graphics segment, amounting to SEK2.18 billion. Its focus is on developing and publishing strategy and management games for PC and consoles across various regions. Paradox Interactive, a Swedish game developer known for its strategy titles, continues to innovate in the high-growth tech sector with significant investments in R&D and product development. The company's recent release of expansions like "Empire of Sin: Hunt for Aurora" and "Archon Prophecy" for Age of Wonders 4 showcases its commitment to enhancing player engagement through new content and features. Despite a one-off loss of SEK 208 million impacting earnings, Paradox's strategic focus on expanding its game universes has led to an expected annual earnings growth of 21.3%, outpacing the Swedish market forecast of 16.9%. This approach not only solidifies its position within the entertainment industry but also aligns with broader trends towards immersive, continuously updated gaming experiences. Get an in-depth perspective on Paradox Interactive's performance by reading our health report here. Explore historical data to track Paradox Interactive's performance over time in our Past section. RaySearch Laboratories Simply Wall St Growth Rating: ★★★★☆☆ Overview: RaySearch Laboratories AB (publ) is a medical technology company that develops software solutions for cancer treatment on a global scale, with a market capitalization of SEK11.48 billion. Operations: RaySearch Laboratories generates revenue primarily from its healthcare software segment, which reported SEK1.27 billion in revenue. RaySearch Laboratories, a leader in oncology treatment software, is making significant strides in the high-growth tech sector with its latest innovations and strategic partnerships. At the recent AAPM event, the company highlighted advancements in adaptive radiotherapy and automated workflows through its RayStation® and RayCare® systems, demonstrating a robust commitment to enhancing cancer treatment efficiency. This focus on cutting-edge technology is complemented by a strategic alliance with Radiology Oncology Systems to expand access to refurbished linear accelerators, showcasing RaySearch's dedication not only to growth but also sustainability in healthcare technology. With these developments and an expected revenue recognition from new installations like Advanced Radiation Therapeutics over the next eight months, RaySearch is poised to maintain its trajectory of innovation-driven growth. Take a closer look at RaySearch Laboratories' potential here in our health report. Gain insights into RaySearch Laboratories' past trends and performance with our Past report. Truecaller Simply Wall St Growth Rating: ★★★★★☆ Overview: Truecaller AB (publ) is a company that develops and publishes mobile caller ID applications for individuals and businesses across India, the Middle East, Africa, and internationally, with a market capitalization of approximately SEK16.51 billion. Operations: The company generates revenue primarily from its communications software segment, amounting to approximately SEK2 billion. Truecaller, a standout in the communications platform sector, is enhancing its market position through strategic executive appointments and innovative product offerings. The recent appointment of Saraswati Agarwal as Regional Sales Head for Ad Solutions underscores Truecaller's commitment to expanding its advertising capabilities, particularly in the MEA region. Financially, Truecaller reported a Q2 sales increase to SEK 506.16 million from SEK 457.87 million year-over-year, although net income slightly decreased to SEK 117.99 million from SEK 123.01 million. This performance is part of a broader trend where Truecaller's annual revenue growth rate stands at 17.7%, with earnings expected to surge by an impressive 24.4% annually over the next three years—outpacing both Swedish market averages and many peers in the tech sector. Navigate through the intricacies of Truecaller with our comprehensive health report here. Evaluate Truecaller's historical performance by accessing our past performance report. Next Steps Get an in-depth perspective on all 53 European High Growth Tech and AI Stocks by using our screener here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OM:PDX OM:RAY B and OM:TRUE B. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
04-08-2025
- Business
- Yahoo
High Growth Tech Stocks To Watch In Europe July 2025
As Europe navigates a landscape marked by tentative optimism surrounding an EU-U.S. trade deal and the European Central Bank's steady interest rates, the pan-European STOXX Europe 600 Index has seen modest gains, reflecting a cautious yet resilient market sentiment. In this environment, high-growth tech stocks in Europe can be particularly appealing to investors looking for innovation-driven opportunities that align with broader economic trends and technological advancements. Top 10 High Growth Tech Companies In Europe Name Revenue Growth Earnings Growth Growth Rating Intellego Technologies 28.42% 47.04% ★★★★★★ Shoper 14.28% 23.79% ★★★★★☆ KebNi 20.56% 94.46% ★★★★★★ Bonesupport Holding 23.98% 62.26% ★★★★★★ Lipigon Pharmaceuticals 104.89% 93.94% ★★★★★☆ Yubico 16.27% 23.90% ★★★★★☆ ContextVision 5.83% 39.78% ★★★★★☆ Aelis Farma 79.30% 106.93% ★★★★★☆ SyntheticMR 18.81% 47.40% ★★★★★☆ CD Projekt 33.57% 40.19% ★★★★★☆ Click here to see the full list of 52 stocks from our European High Growth Tech and AI Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Pharming Group Simply Wall St Growth Rating: ★★★★☆☆ Overview: Pharming Group N.V. is a biopharmaceutical company that focuses on developing and commercializing protein replacement therapies and precision medicines for rare diseases across the United States, Europe, and other international markets, with a market cap of €596.08 million. Operations: Pharming Group generates revenue primarily through its Recombinant Human C1 Esterase Inhibitor business, which accounts for $320.71 million. The company's focus is on providing treatments for rare diseases in various international markets. Pharming Group N.V. is navigating a complex landscape with an 8.3% expected annual revenue growth, which, although modest compared to some high-growth sectors, outpaces the Dutch market's 7.3%. The company's commitment to innovation is underscored by its significant R&D efforts aimed at tackling rare diseases like APDS; this focus not only differentiates it within the biotech industry but also enhances its potential in a niche market. Recent announcements include the hosting of a webcast to discuss groundbreaking findings in immune disorders and an upgrade in revenue guidance for 2025 to USD 325-340 million, reflecting positive business momentum. These developments suggest Pharming is strategically poised to leverage scientific advances into commercial success, despite current unprofitability and market challenges. Dive into the specifics of Pharming Group here with our thorough health report. Assess Pharming Group's past performance with our detailed historical performance reports. BioInvent International Simply Wall St Growth Rating: ★★★★★☆ Overview: BioInvent International AB (publ) is a clinical-stage company focused on discovering and developing immuno-modulatory antibodies for cancer treatment, with a market cap of approximately SEK2.64 billion. Operations: The company generates revenue primarily from developing antibody-based drugs, amounting to SEK60.80 million. BioInvent International is making significant strides in the biotech sector, particularly with its innovative BI-1808 treatment for cutaneous T-cell lymphoma (CTCL), demonstrating a 100% disease control rate in recent trials. This promising performance is underpinned by a robust annual revenue growth forecast of 76.6% and an earnings growth projection of 91.77%. With R&D expenses aligned to propel future innovations, BioInvent not only surpasses the Swedish market's growth rate of 5.2% but also outpaces biotech industry norms, positioning it well for upcoming profitability within three years. Click here and access our complete health analysis report to understand the dynamics of BioInvent International. Gain insights into BioInvent International's past trends and performance with our Past report. Bonesupport Holding Simply Wall St Growth Rating: ★★★★★★ Overview: Bonesupport Holding AB (publ) is an orthobiologics company that specializes in developing and selling injectable bio-ceramic bone graft substitutes across Europe, North America, and other international markets, with a market cap of SEK21.76 billion. Operations: Bonesupport Holding AB generates revenue primarily from its pharmaceuticals segment, amounting to SEK1.06 billion. The company focuses on the development and sale of injectable bio-ceramic bone graft substitutes across various regions, including Europe and North America. Bonesupport Holding's recent financial performance underscores its potential within the European tech landscape, with a notable increase in Q2 sales to SEK 284.43 million from SEK 219.8 million the previous year, and net income more than doubling to SEK 53.07 million. This growth trajectory is complemented by an ambitious R&D strategy, critical for maintaining technological leadership and competitiveness. The company's robust revenue growth rate of 24% annually outpaces the broader Swedish market's growth of 5.2%, positioning it well for sustained advancements in its sector. Additionally, with earnings expected to surge by 62.3% annually, Bonesupport is poised to capitalize on expanding market opportunities while enhancing shareholder value through strategic reinvestments in innovation and market expansion initiatives. Take a closer look at Bonesupport Holding's potential here in our health report. Review our historical performance report to gain insights into Bonesupport Holding's's past performance. Seize The Opportunity Dive into all 52 of the European High Growth Tech and AI Stocks we have identified here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Ready For A Different Approach? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTAM:PHARM OM:BINV and OM:BONEX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
04-08-2025
- Business
- Yahoo
High Growth Tech Stocks In Europe To Watch July 2025
The European market has shown tentative optimism as the pan-European STOXX Europe 600 Index rose by 0.54%, buoyed by hopes of a potential EU-U.S. trade deal and steady interest rates from the European Central Bank, despite lingering uncertainties in global trade dynamics. In this environment, high-growth tech stocks in Europe become particularly intriguing to investors seeking opportunities that align with current market conditions, where resilience and adaptability to geopolitical changes are key factors for success. Top 10 High Growth Tech Companies In Europe Name Revenue Growth Earnings Growth Growth Rating Intellego Technologies 28.42% 47.04% ★★★★★★ KebNi 20.56% 65.02% ★★★★★★ Comet Holding 12.58% 32.19% ★★★★★☆ Lipigon Pharmaceuticals 104.89% 93.94% ★★★★★☆ Yubico 16.27% 23.90% ★★★★★☆ Bonesupport Holding 23.98% 62.26% ★★★★★★ ContextVision 5.83% 39.78% ★★★★★☆ SyntheticMR 18.81% 47.40% ★★★★★☆ Aelis Farma 79.30% 106.93% ★★★★★☆ CD Projekt 33.57% 40.19% ★★★★★☆ Click here to see the full list of 51 stocks from our European High Growth Tech and AI Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Pexip Holding Simply Wall St Growth Rating: ★★★★☆☆ Overview: Pexip Holding ASA is a video technology company that offers a comprehensive video conferencing platform and digital infrastructure across multiple regions including the Americas, Europe, the Middle East, Africa, and the Asia Pacific with a market capitalization of NOK6.25 billion. Operations: Pexip generates revenue primarily through the sale of collaboration services, amounting to NOK1.17 billion. Pexip Holding's recent strategic moves, including a share repurchase program and robust quarterly earnings growth, underscore its upward trajectory in the high-tech sector. With a revenue increase to NOK 347.95 million from NOK 291.98 million year-over-year and net income rising to NOK 66.37 million from NOK 45.41 million, the company is demonstrating solid financial health. Notably, Pexip's commitment to innovation is evident as it earmarks substantial funds (NOK 100 million) for share-based compensation plans through its buyback strategy, aligning interests with long-term shareholder value and employee incentives. This approach not only enhances capital efficiency but also positions Pexip favorably within Europe's competitive tech landscape as it continues to outpace average market growth with a projected annual revenue increase of 9.4% and earnings growth of 25.5%. Click here and access our complete health analysis report to understand the dynamics of Pexip Holding. Evaluate Pexip Holding's historical performance by accessing our past performance report. CD Projekt Simply Wall St Growth Rating: ★★★★★☆ Overview: CD Projekt S.A. is a Polish company that, along with its subsidiaries, focuses on developing, publishing, and digitally distributing video games for personal computers and consoles, with a market capitalization of PLN25.19 billion. Operations: CD Projekt, along with its subsidiaries, generates revenue primarily through CD PROJEKT RED, contributing PLN795.50 million, and adding PLN203.79 million. The company focuses on video game development and distribution for PCs and consoles in Poland. CD Projekt, navigating through a challenging landscape with a slight dip in quarterly revenue to PLN 226.31 million from PLN 226.79 million, still managed to maintain robust projections with expected annual revenue growth at an impressive 33.6%. Despite a recent decline in net income from PLN 100.06 million to PLN 86 million, the company is poised for significant earnings expansion, forecasted at an annual rate of 40.2%. This growth trajectory is bolstered by strategic R&D investments aimed at fostering innovation and securing its competitive edge in the dynamic gaming industry. These financial and strategic maneuvers highlight CD Projekt's resilience and adaptability within Europe's tech sector, underscoring its potential amidst evolving market demands and consumer preferences. Click here to discover the nuances of CD Projekt with our detailed analytical health report. Understand CD Projekt's track record by examining our Past report. Shoper Simply Wall St Growth Rating: ★★★★☆☆ Overview: Shoper S.A. is a Polish company offering Software as a Service solutions for e-commerce, with a market capitalization of PLN1.35 billion. Operations: Shoper S.A. generates revenue primarily through its Solutions segment, contributing PLN157.26 million, and Subscriptions, adding PLN43.08 million. Shoper S.A. has demonstrated a robust growth trajectory, with earnings surging by 37.8% over the past year, outpacing the software industry's average of 20.9%. This growth is underpinned by a significant annual revenue increase of 14.3%, which exceeds the broader Polish market's growth rate of 4.5%. Notably, Shoper's strategic focus on R&D has been crucial in maintaining its competitive edge and fostering innovation within the tech landscape. The firm's recent financial results reflect this momentum, with first-quarter revenue climbing to PLN 51.73 million from PLN 44.19 million year-over-year and net income rising to PLN 9.84 million from PLN 7.76 million in the same period last year, signaling strong operational performance and potential for sustained growth. Unlock comprehensive insights into our analysis of Shoper stock in this health report. Review our historical performance report to gain insights into Shoper's's past performance. Make It Happen Access the full spectrum of 51 European High Growth Tech and AI Stocks by clicking on this link. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OB:PEXIP WSE:CDR and WSE:SHO. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
23-07-2025
- Business
- Yahoo
High Growth Tech Stocks in Europe to Watch July 2025
The European market has shown mixed results recently, with the pan-European STOXX Europe 600 Index remaining relatively flat as investors await developments in U.S. and European trade discussions. Amid these conditions, high growth tech stocks in Europe present intriguing opportunities for investors seeking exposure to sectors driven by innovation and resilience, especially given the backdrop of fluctuating economic indicators and regional trade dynamics. Top 10 High Growth Tech Companies In Europe Name Revenue Growth Earnings Growth Growth Rating Intellego Technologies 28.42% 47.04% ★★★★★★ Archos 24.72% 39.34% ★★★★★★ KebNi 20.56% 94.46% ★★★★★★ Pharma Mar 26.67% 43.29% ★★★★★★ innoscripta 24.76% 26.32% ★★★★★★ Bonesupport Holding 23.98% 62.26% ★★★★★★ Skolon 31.51% 99.52% ★★★★★★ Xbrane Biopharma 24.95% 56.77% ★★★★★★ Rubean 45.56% 108.82% ★★★★★★ Elliptic Laboratories 36.33% 78.99% ★★★★★★ Click here to see the full list of 231 stocks from our European High Growth Tech and AI Stocks screener. Let's review some notable picks from our screened stocks. LINK Mobility Group Holding Simply Wall St Growth Rating: ★★★★☆☆ Overview: LINK Mobility Group Holding ASA, along with its subsidiaries, offers mobile and communication-platform-as-a-service solutions and has a market capitalization of NOK8.69 billion. Operations: The company generates revenue primarily from four segments: Central Europe (NOK1.73 billion), Western Europe (NOK2.14 billion), Northern Europe (NOK1.55 billion), and Global Messaging (NOK1.55 billion). LINK Mobility Group Holding ASA demonstrates robust growth dynamics within the European tech landscape, notably with its earnings surging by 61% over the past year, outpacing the software industry's average of 14.8%. This growth trajectory is bolstered by strategic financial activities including a recent senior unsecured bond placement of EUR 100 million aimed at refinancing existing debt, showcasing proactive capital management. Despite a challenging quarter with net income dropping to NOK 39.26 million from NOK 253.05 million year-over-year due to significant one-off losses, LINK continues to innovate and expand its market presence. The firm's commitment to leveraging advanced technology solutions for mobile communications positions it well for sustained growth, albeit mindful of fluctuating quarterly earnings impacted by non-recurring costs. Click here and access our complete health analysis report to understand the dynamics of LINK Mobility Group Holding. Evaluate LINK Mobility Group Holding's historical performance by accessing our past performance report. Hemnet Group Simply Wall St Growth Rating: ★★★★★☆ Overview: Hemnet Group AB (publ) operates a residential property platform in Sweden with a market cap of SEK28.21 billion. Operations: The company generates revenue primarily through listing fees, value-added services, and advertising on its platform. It experiences a notable gross profit margin of 71.5%, indicating efficient cost management relative to its revenue streams. Hemnet Group's recent performance underscores its robust position in the tech sector, with a notable increase in net income to SEK 185 million from SEK 148.7 million year-over-year for Q2 2025, reflecting a growth of 24.4%. This upward trajectory is supported by strategic share repurchases, with the company buying back over 1.3 million shares for SEK 449.8 million within the past year, signaling confidence in its financial health and commitment to shareholder value. Additionally, Hemnet's revenue surged by nearly 19% annually to SEK 813 million over six months, outpacing general market trends and highlighting its effective business model amid competitive digital marketplaces. Click to explore a detailed breakdown of our findings in Hemnet Group's health report. Gain insights into Hemnet Group's past trends and performance with our Past report. HMS Networks Simply Wall St Growth Rating: ★★★★☆☆ Overview: HMS Networks AB (publ) provides products facilitating communication and information sharing for industrial equipment globally, with a market cap of SEK20.94 billion. Operations: HMS Networks AB (publ) focuses on developing and supplying communication solutions for industrial equipment, enabling seamless data exchange globally. The company operates with a market capitalization of SEK20.94 billion. HMS Networks, a player in the European tech landscape, demonstrates robust growth with its revenue expected to rise by 14.2% annually. This outpaces the Swedish market's average of 5.1%, underscoring HMS's effective market strategies and innovation focus. The company also reported a significant jump in net income from SEK 34 million to SEK 84 million in Q2 2025 alone, reflecting an impressive annual earnings growth forecast of 33.5%. Despite opting not to pay dividends this year, HMS's commitment to R&D investments and operational enhancements suggest a strategic pivot towards long-term value creation and technological leadership within its sector. Unlock comprehensive insights into our analysis of HMS Networks stock in this health report. Examine HMS Networks' past performance report to understand how it has performed in the past. Summing It All Up Investigate our full lineup of 231 European High Growth Tech and AI Stocks right here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OB:LINK OM:HEM and OM:HMS. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
14-07-2025
- Business
- Yahoo
Global Growth Companies With High Insider Ownership Expecting Up To 120% Earnings Growth
In a global market environment where tariff announcements and mixed economic signals are creating uncertainty, growth stocks have shown resilience, particularly as the Nasdaq Composite Index has managed to hold up better than its peers. Amidst these conditions, companies with high insider ownership often attract attention due to the confidence they exhibit in their own potential for earnings growth. Name Insider Ownership Earnings Growth Zhejiang Leapmotor Technology (SEHK:9863) 15.6% 60.6% Shanghai Huace Navigation Technology (SZSE:300627) 24.3% 23.5% Samyang Foods (KOSE:A003230) 11.7% 25.7% Pharma Mar (BME:PHM) 11.8% 44.9% Novoray (SHSE:688300) 23.6% 27.1% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% Laopu Gold (SEHK:6181) 35.5% 42.2% KebNi (OM:KEBNI B) 38.3% 94.5% Fulin Precision (SZSE:300432) 13.6% 43.7% Elliptic Laboratories (OB:ELABS) 24.4% 79% Click here to see the full list of 830 stocks from our Fast Growing Global Companies With High Insider Ownership screener. Let's review some notable picks from our screened stocks. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Zhejiang XCC Group Co., Ltd specializes in the research, development, manufacture, and sale of bearings across various international markets including the United States, Japan, Korea, and Brazil, with a market cap of CN¥12.08 billion. Operations: Zhejiang XCC Group Co., Ltd generates revenue primarily through the research, development, manufacturing, and sale of bearings in international markets such as the United States, Japan, Korea, and Brazil. Insider Ownership: 31.9% Earnings Growth Forecast: 42.8% p.a. Zhejiang XCC Group Ltd. demonstrates significant insider ownership, aligning with its robust growth potential. The company's earnings are forecast to grow substantially at 42.8% annually, outpacing the Chinese market average of 23.4%. Despite recent margin contraction from 4.4% to 2.7%, revenue is expected to increase by 13.3% per year, surpassing the market's growth rate of 12.4%. The recent CNY1 billion private placement supports further expansion initiatives and underscores management's commitment to growth strategies. Take a closer look at Zhejiang XCC GroupLtd's potential here in our earnings growth report. Our valuation report here indicates Zhejiang XCC GroupLtd may be overvalued. Simply Wall St Growth Rating: ★★★★★☆ Overview: Jiangxi Chenguang New Materials Company Limited is a special chemical company that develops, produces, and sells functional silane raw materials, intermediates, and downstream products both in China and internationally, with a market cap of CN¥4.74 billion. Operations: The company generates revenue primarily from its functional silane segment, amounting to CN¥1.12 billion. Insider Ownership: 35.1% Earnings Growth Forecast: 64.6% p.a. Jiangxi Chenguang New Materials shows strong growth potential with earnings forecast to grow significantly at 64.6% annually, outpacing the Chinese market average. Despite a recent net loss of CNY 4.73 million and reduced profit margins, revenue is expected to increase by 23% per year, exceeding market growth rates. However, return on equity is forecasted to remain low at 3.2%, and dividends are not well covered by earnings or free cash flows. Unlock comprehensive insights into our analysis of Jiangxi Chenguang New Materials stock in this growth report. The valuation report we've compiled suggests that Jiangxi Chenguang New Materials' current price could be inflated. Simply Wall St Growth Rating: ★★★★★☆ Overview: Jiangsu Huahong Technology Co., Ltd. operates in the research, development, manufacturing, marketing, and servicing of renewable resource processing equipment both in China and internationally, with a market cap of CN¥6.01 billion. Operations: Jiangsu Huahong Technology's revenue primarily stems from its operations in the research, development, manufacturing, marketing, and servicing of renewable resource processing equipment within China and on an international scale. Insider Ownership: 18.1% Earnings Growth Forecast: 120% p.a. Jiangsu Huahong Technology is positioned for substantial growth, with revenue expected to rise by 22.5% annually, surpassing the Chinese market's average. The company recently reported a return to profitability in Q1 2025 with CNY 31.13 million net income, compared to a loss last year. Despite previous annual losses and declining sales, forecasts indicate it will become profitable within three years, highlighting its potential as a growth-oriented investment opportunity amidst high insider ownership dynamics. Click here and access our complete growth analysis report to understand the dynamics of Jiangsu Huahong Technology. The analysis detailed in our Jiangsu Huahong Technology valuation report hints at an deflated share price compared to its estimated value. Delve into our full catalog of 830 Fast Growing Global Companies With High Insider Ownership here. Interested In Other Possibilities? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SHSE:603667 SHSE:605399 and SZSE:002645. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data
